Completed PHASE1 INTERVENTIONAL 5-arm NCT01548170

To Assess the Interaction Between Sunitinib and Ketoconazole to Reduce the Dose and Cost of Sunitinib

A Phase I, Pilot, Dose Finding Clinical Trial to Assess the Interaction Between Sunitinib and Ketoconazole to Reduce the Dose and Cost of Sunitinib for National Health System

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Conditions Cancer

Interventions Sunitiinb and Ketoconazol Sunitinib Sunitinib and Ketoconazol

Updated 5 times since 2017 Last updated: Mar 5, 2012 Started: Apr 30, 2011 Primary completion: Jul 31, 2011 Completion: Jul 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01548170, this PHASE1 trial focuses on Cancer and remains completed. Sponsored by Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal, it has been updated 5 times since 2011, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Apr 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Data source: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madrid, Spain